CS182300B2 - Process for preparing 1,3-oxidated 8alfa-estratrienes - Google Patents

Process for preparing 1,3-oxidated 8alfa-estratrienes

Info

Publication number
CS182300B2
CS182300B2 CS7600001694A CS169476A CS182300B2 CS 182300 B2 CS182300 B2 CS 182300B2 CS 7600001694 A CS7600001694 A CS 7600001694A CS 169476 A CS169476 A CS 169476A CS 182300 B2 CS182300 B2 CS 182300B2
Authority
CS
Czechoslovakia
Prior art keywords
8alfa
estratrienes
oxidated
preparing
oxidated 8alfa
Prior art date
Application number
CS7600001694A
Other languages
Czech (cs)
Inventor
Klaus Prezewowsky
Henry Laurent
Helmut Hofmeister
Rudolf Wiechert
Friedmund Neumann
Yukishige Nishino
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2336431A external-priority patent/DE2336431C2/en
Priority claimed from DE19742426777 external-priority patent/DE2426777A1/en
Application filed by Schering Ag filed Critical Schering Ag
Publication of CS182300B2 publication Critical patent/CS182300B2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J15/00Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
CS7600001694A 1973-07-13 1974-07-12 Process for preparing 1,3-oxidated 8alfa-estratrienes CS182300B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2336431A DE2336431C2 (en) 1973-07-13 1973-07-13 1.3-oxygenated 8-alpha-estratrienes, processes for their production and pharmaceuticals containing them
DE19742426777 DE2426777A1 (en) 1974-05-31 1974-05-31 1,3-Oxygenated-8-alpha-oestratrienes for post-menopausal disorders - with vaginotropic, but low uterotrophic activity

Publications (1)

Publication Number Publication Date
CS182300B2 true CS182300B2 (en) 1978-04-28

Family

ID=25765510

Family Applications (2)

Application Number Title Priority Date Filing Date
CS7600001694A CS182300B2 (en) 1973-07-13 1974-07-12 Process for preparing 1,3-oxidated 8alfa-estratrienes
CS7400004984A CS182260B2 (en) 1973-07-13 1974-07-12 Method of producing 1,3-oxidated 8alfa-estratrienes

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS7400004984A CS182260B2 (en) 1973-07-13 1974-07-12 Method of producing 1,3-oxidated 8alfa-estratrienes

Country Status (18)

Country Link
JP (1) JPS5821639B2 (en)
AT (1) ATA575574A (en)
AU (1) AU477010B2 (en)
CA (1) CA1030951A (en)
CH (2) CH609064A5 (en)
CS (2) CS182300B2 (en)
DD (1) DD114066A5 (en)
DK (1) DK133051C (en)
ES (1) ES428226A1 (en)
FI (1) FI54131C (en)
FR (1) FR2236505B1 (en)
GB (1) GB1479934A (en)
HU (1) HU169791B (en)
IE (1) IE39872B1 (en)
IL (1) IL45259A (en)
NO (1) NO742546L (en)
SE (1) SE7409151L (en)
SU (1) SU626705A3 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2551214C2 (en) * 1975-11-12 1984-07-12 Schering AG, 1000 Berlin und 4709 Bergkamen Process for the preparation of 1,3-oxygenated 8α-estatrienes
JPS5862734U (en) * 1981-10-22 1983-04-27 日工株式会社 formwork support sabot
JPS59146759A (en) * 1984-01-06 1984-08-22 株式会社日立製作所 Automatic screwing device
JPS60155376A (en) * 1984-01-24 1985-08-15 松下電器産業株式会社 Nut float detection apparatus
DE3710728A1 (en) * 1987-03-31 1988-10-13 Schering Ag METHOD FOR PRODUCING 17 (ALPHA) -ETHINYL-17SS-HYDROXY-18-METHYL-4.15-ESTRADIEN-3-ON AND THE NEW INTERMEDIATE PRODUCTS FOR THIS METHOD
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
US6903084B2 (en) 1991-08-29 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
RU2679625C1 (en) * 2018-11-08 2019-02-12 Ильясов Шамиль Сионович 3-o-sulfamoiloxy-6-oxa-7β-methyl-d-homo-8α-estra-1,3,5(10)-trien-17α-one application for the breast cancer treatment, including the triple negative form, and its production method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3436411A (en) * 1967-12-28 1969-04-01 American Home Prod Process for cleaving an a-ring ether group in 13-alkylgona (and 8-isogona)-1,3,5(10)-trienes and delta-7-,delta-8(9)-,and delta-8(9),14(15)-dehydro derivatives thereof

Also Published As

Publication number Publication date
SE7409151L (en) 1975-01-14
DK133051C (en) 1976-08-16
DK133051B (en) 1976-03-15
IE39872B1 (en) 1979-01-17
GB1479934A (en) 1977-07-13
FI213974A (en) 1975-01-14
CH614217A5 (en) 1979-11-15
CH609064A5 (en) 1979-02-15
IL45259A0 (en) 1974-10-22
CS182260B2 (en) 1978-04-28
CA1030951A (en) 1978-05-09
ATA575574A (en) 1978-05-15
FR2236505B1 (en) 1977-07-08
FI54131B (en) 1978-06-30
DK368074A (en) 1975-03-17
JPS5032160A (en) 1975-03-28
DD114066A5 (en) 1975-07-12
FR2236505A1 (en) 1975-02-07
JPS5821639B2 (en) 1983-05-02
SU626705A3 (en) 1978-09-30
IL45259A (en) 1977-10-31
ES428226A1 (en) 1976-07-16
IE39872L (en) 1975-01-13
AU477010B2 (en) 1976-10-14
HU169791B (en) 1977-01-28
NO742546L (en) 1975-02-10
FI54131C (en) 1978-10-10
AU7112374A (en) 1976-01-15

Similar Documents

Publication Publication Date Title
YU39603B (en) Process for preparing triazolyl-o,n-acetals
YU282474A (en) Process for obtaining 1,2-benzisooxazole derivatives
YU235174A (en) Process for preparing dodeca-7,9-diene-1-yl-acetate
CA1022191A (en) Process for preparing 2,6-dimethylnaphthalenes
ZA743234B (en) Process for preparing 3,4-dihydro-1,2,3-oxathiazine-4-ones
CA1019334A (en) Process for preparing 2,4-dimethyl-3-carboxanilido-or carboxanaphthylamido-furan
CS183763B2 (en) Process for preparing d-homosteroides
CS182300B2 (en) Process for preparing 1,3-oxidated 8alfa-estratrienes
YU39722B (en) Process for obtaining 0,0-diethyldithio-phoshoryl-methyl-3-chloro-6-benzoxazolone
CA1030541A (en) Process for preparing 4,5-diphenyl-oxazol-2-one
YU301580A (en) Process for obtaining new 2,4-diamino-benzylpyrimidines
YU45274A (en) Process for preparing new substituted 2-phenylamino-imidazoline-(2)
YU177974A (en) Process for preparing 2-carbalkoxy-amino-benzimidazole-5(6)-phenylethers
HU171222B (en) Process for preparing substituted 2,1,3-benzothiadiazin-4-on-2,2-dioxides
YU206774A (en) Process for obtaining 3,4-diamino-benzophenones
CS183759B2 (en) Process for preparing acylaminophenylacetamidines
HU172290B (en) Process for preparing substituted 7h-indolizino/5,6,7-ij/-isoquinoline
HU171180B (en) Process for preparing 4,5-seco-steroids
YU178074A (en) Process for preparing 2-carbalkoxy-amino-benzimidazole-5(6)-phenylethers
YU341974A (en) Process for preparing 4-amino-1,2,4-triazine-5-ones
HU170762B (en) Process for producing 2,6-dinitro-aniline derivatives
CS182269B2 (en) Process for preparing alkylnaphtalenes
KR780000654B1 (en) Process for preparing 11,12-secoprostaglandins
CS189820B1 (en) Process for preparing 2,5-dichlor-1,4-phenylendiamine
HU172933B (en) Process for preparing 3,4-dihydro-1-benzoxepin-5-on-oxime ethers